| Product NDC: | 52083-239 |
| Proprietary Name: | TUSICOF |
| Non Proprietary Name: | dextromethorphan, guaifenesin, and phenylephrine |
| Active Ingredient(s): | 20; 400; 10 mg/5mL; mg/5mL; mg/5mL & nbsp; dextromethorphan, guaifenesin, and phenylephrine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SYRUP |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52083-239 |
| Labeler Name: | Kramer Novis |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20100817 |
| Package NDC: | 52083-239-04 |
| Package Description: | 120 mL in 1 BOTTLE (52083-239-04) |
| NDC Code | 52083-239-04 |
| Proprietary Name | TUSICOF |
| Package Description | 120 mL in 1 BOTTLE (52083-239-04) |
| Product NDC | 52083-239 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | dextromethorphan, guaifenesin, and phenylephrine |
| Dosage Form Name | SYRUP |
| Route Name | ORAL |
| Start Marketing Date | 20100817 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Kramer Novis |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 20; 400; 10 |
| Strength Unit | mg/5mL; mg/5mL; mg/5mL |
| Pharmaceutical Classes |